A comprehensive view of Approved Drugs / Devices. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Government & Public Policy Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Pfizer Announces 2024 Shareholder Meeting Preliminary Results
Published: April 25, 2024 by Pfizer Inc.
European Patent Office Receives Amgen Inc's Patent Application for Engineered NRG-1 Variants with Improved Selectivity Toward Erbb4 But Not Against ERBB3
Published: April 25, 2024 by Pharmaceutical Patent News
Eli Lilly and Company Submits European Patent Application for Peptides Comprising N-Formyl-Halogenated Methionine Residues and Engineered Antibody-Peptide Conjugates Thereof
Published: April 25, 2024 by Biotechnology Patent News
Sage Therapeutics Announces First Quarter 2024 Financial Results and Highlights Pipeline and Business Progress
Published: April 25, 2024 by Sage Therapeutics
Bristol-Myers Squibb Co Files Patent Application for Crystal form Of 6-(Cyclopropanecarboxamido)-4-((2-Methoxy-3-(1-Methyl-1h- 1,2,4-Triazol-3-Yl) Phenyl)Amino)-N-(Methyl-D3) Pyridazine-3-Carboxamide
Published: April 25, 2024 by Indian Patents News

Ask us about our Government & Public Policy market view

Trending Chart

Interactive chart with headline count